• / Free eNewsletters & Magazine
  • / My Account
Home>Novartis, GlaxoSmithKline Complete Deals

Novartis, GlaxoSmithKline Complete Deals

3party Content

Mon, 2 Mar 2015

ZURICH--Novartis AG (NOVN.VX) and GlaxoSmithKline PLC (GSK.LN) said Monday they had closed a series of transactions worth more than $20 billion that will fundamentally reshape both of the drug giants. Basel-based Novartis said the deal, which was announced in April last year, refocuses the
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.